Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment

被引：89
|
作者：
Fioretto, Paola [1 ]
Stefansson, Bergur V. [2 ]
Johnsson, Eva [2 ]
Cain, Valerie A. [3 ]
Sjostrom, C. David [2 ]
机构：
[1] Univ Padua, Dept Med, Clin Med 3, Via Giustiniani 2, I-35128 Padua, Italy
[2] AstraZeneca, Molndal, Sweden
[3] AstraZeneca, Wilmington, DE USA
来源：
DIABETOLOGIA | 2016年 / 59卷 / 09期
关键词：
Albuminuria; Dapagliflozin; Renal impairment; SGLT2; inhibition; Type; 2; diabetes; BLOOD-PRESSURE;
D O I：
10.1007/s00125-016-4017-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2036 / 2039
页数：4
相关论文
共 50 条
  • [1] Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment
    Paola Fioretto
    Bergur V. Stefansson
    Eva Johnsson
    Valerie A. Cain
    C. David Sjöström
    [J]. Diabetologia, 2016, 59 : 2036 - 2039
  • [2] Dapagliflozin in patients with type 2 diabetes mellitus
    Filippatos, Theodosios D.
    Liberopoulos, Evangelos N.
    Elisaf, Moses S.
    [J]. THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (01) : 29 - 41
  • [3] EFFECT OF DAPAGLIFLOZIN ON ALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES AND CKD
    Abdullaev, Sherzod
    Sharapov, Olimkhon
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I685 - I686
  • [4] Vildagliptin in patients with type 2 diabetes mellitus and renal impairment
    Groop, Per-Henrik
    Dongre, Neelesh
    Kothny, Wolfgang
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 (02) : E12 - E13
  • [5] Effect of Dapagliflozin on renal protection in patients with uncontrolled type 2 diabetes mellitus
    张德园
    [J]. China Medical Abstracts (Internal Medicine), 2020, 37 (01) : 21 - 22
  • [6] Effect of dapagliflozin on renal and cardiac function in patients with type 2 diabetes and albuminuria: a randomised study
    Eickhoff, M. K.
    Olsen, F. J.
    Frimodt-Moller, M.
    Diaz, L. J.
    Jensen, M. T.
    Rossing, P.
    Persson, F.
    [J]. DIABETOLOGIA, 2018, 61 : S299 - S300
  • [7] An Exploratory Study of Dapagliflozin for the Attenuation of Albuminuria in Patients with Heart Failure and Type 2 Diabetes Mellitus (DAPPER)
    Yoshihara, Fumiki
    Imazu, Miki
    Hamasaki, Toshimitsu
    Anzai, Toshihisa
    Yasuda, Satoshi
    Ito, Shin
    Yamamoto, Haruko
    Hashimura, Kazuhiko
    Yasumura, Yoshio
    Mori, Kiyoshi
    Watanabe, Masataka
    Asakura, Masanori
    Kitakaze, Masafumi
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2018, 32 (02) : 183 - 190
  • [8] An Exploratory Study of Dapagliflozin for the Attenuation of Albuminuria in Patients with Heart Failure and Type 2 Diabetes Mellitus (DAPPER)
    Fumiki Yoshihara
    Miki Imazu
    Toshimitsu Hamasaki
    Toshihisa Anzai
    Satoshi Yasuda
    Shin Ito
    Haruko Yamamoto
    Kazuhiko Hashimura
    Yoshio Yasumura
    Kiyoshi Mori
    Masataka Watanabe
    Masanori Asakura
    Masafumi Kitakaze
    [J]. Cardiovascular Drugs and Therapy, 2018, 32 : 183 - 190
  • [9] Sitagliptin reduces albuminuria in patients with type 2 diabetes
    Hattori, Sachiko
    [J]. ENDOCRINE JOURNAL, 2011, 58 (01) : 69 - 73
  • [10] Hyperuricemia and Albuminuria in Patients With Type 2 Diabetes Mellitus
    Bonakdaran, Shokoofeh
    Hami, Maryam
    Shakeri, Mohammad Taghi
    [J]. IRANIAN JOURNAL OF KIDNEY DISEASES, 2011, 5 (01) : 21 - 24
12345